Woolcock researchers release care pathways for respiratory allergy

People with allergic rhinitis or asthma who might benefit from allergen immunotherapy aren’t  getting identified and onto the long treatment pathway which could potentially be life changing, Australian experts say. Professor Sinthia Bosnic-Anticevich, from the Woolcock Institute of Medical Research, told the limbic that while allergen immunotherapy was usually delivered by specialists, the first step ...

Already a member?

Login to keep reading.

© 2021 the limbic